Alzheimer’s disease: many failed trials, so where do we go from here?
Allison Bethanne Reiss, Amy D Glass, Thomas Wisniewski, Benjamin Wolozin, Irving H Gomolin, Aaron Pinkhasov, Joshua De Leon, Mark M Stecker
DOI: 10.1136/jim-2020-001297 Published 29 July 2020
Allison Bethanne Reiss
1
Medicine, NYU Long Island School of Medicine and NYU Winthrop Hospital, Mineola, New York, USA
Amy D Glass
1
Medicine, NYU Long Island School of Medicine and NYU Winthrop Hospital, Mineola, New York, USA
Thomas Wisniewski
2
Departments of Neurology, Pathology and Psychiatry, New York University School of Medicine, New York, New York, USA
Benjamin Wolozin
3
Departments of Pharmacology and Neurology, Boston University School of Medicine, Boston, Massachusetts, USA
Irving H Gomolin
1
Medicine, NYU Long Island School of Medicine and NYU Winthrop Hospital, Mineola, New York, USA
Aaron Pinkhasov
4
Department of Psychiatry, NYU Winthrop Hospital, Mineola, New York, USA
Joshua De Leon
1
Medicine, NYU Long Island School of Medicine and NYU Winthrop Hospital, Mineola, New York, USA
Mark M Stecker
5
Neurology, UCSF San Francisco/Fresno, Fresno, California, USA
Submit a Response to This Article
No eLetters have been published for this article.
Alzheimer’s disease: many failed trials, so where do we go from here?
Allison Bethanne Reiss, Amy D Glass, Thomas Wisniewski, Benjamin Wolozin, Irving H Gomolin, Aaron Pinkhasov, Joshua De Leon, Mark M Stecker
Journal of Investigative Medicine Aug 2020, 68 (6) 1135-1140; DOI: 10.1136/jim-2020-001297
Alzheimer’s disease: many failed trials, so where do we go from here?
Allison Bethanne Reiss, Amy D Glass, Thomas Wisniewski, Benjamin Wolozin, Irving H Gomolin, Aaron Pinkhasov, Joshua De Leon, Mark M Stecker
Journal of Investigative Medicine Aug 2020, 68 (6) 1135-1140; DOI: 10.1136/jim-2020-001297
Alzheimer’s disease: many failed trials, so where do we go from here?
Allison Bethanne Reiss, Amy D Glass, Thomas Wisniewski, Benjamin Wolozin, Irving H Gomolin, Aaron Pinkhasov, Joshua De Leon, Mark M Stecker
Journal of Investigative Medicine Aug 2020, 68 (6) 1135-1140; DOI: 10.1136/jim-2020-001297